drugset / Trial / NCT00003603

Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma

NCT00003603

Phase 3 Unknown 660 enrolled Riverside Haematology Group
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Steroids, such as dexamethasone or prednisolone, may help relieve some of the side effects of chemotherapy. It is not yet known which regimen of chemotherapy plus steroid therapy is more effective in treating patients with multiple myeloma. PURPOSE: Randomized phase III trial to compare the effectiveness of two different regimens of chemotherapy plus steroid therapy in treating patients with multiple myeloma that has recurred for the first time.

Timeline

Start
1998-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule Oral
Subject Idarubicin Small molecule Oral
Subject Lomustine Small molecule Oral
Subject Melphalan Small molecule Oral
Subject Prednisolone Other / unclassified Oral
Background Cyclophosphamide Other / unclassified Oral

Indications